Literature DB >> 22284893

Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization.

Erik R Vandermark1, Krysta A Deluca, Courtney R Gardner, Daniel F Marker, Cynthia N Schreiner, David A Strickland, Katelynn M Wilton, Sumona Mondal, Craig D Woodworth.   

Abstract

The NF-kB family of transcription factors regulates important biological functions including cell growth, survival and the immune response. We found that Human Papillomavirus type 16 (HPV-16) E7 and E6/E7 proteins inhibited basal and TNF-alpha-inducible NF-kB activity in human epithelial cells cultured from the cervical transformation zone, the anatomic region where most cervical cancers develop. In contrast, HPV-16 E6 regulated NF-kB in a cell type- and cell growth-dependent manner. NF-kB influenced immortalization of cervical cells by HPV16. Inhibition of NF-kB by an IkB alpha repressor mutant increased colony formation and immortalization by HPV-16. In contrast, activation of NF-kB by constitutive expression of p65 inhibited proliferation and immortalization. Our results suggest that inhibition of NF-kB by HPV-16 E6/E7 contributes to immortalization of cells from the cervical transformation zone.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284893      PMCID: PMC3289550          DOI: 10.1016/j.virol.2011.12.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  55 in total

Review 1.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

3.  Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin.

Authors:  Kaede Hinata; Adam M Gervin; Y Jennifer Zhang; Paul A Khavari
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

4.  NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.

Authors:  Mei Xu; Rachel A Katzenellenbogen; Carla Grandori; Denise A Galloway
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1.

Authors:  S E Perea; P Massimi; L Banks
Journal:  Int J Mol Med       Date:  2000-06       Impact factor: 4.101

7.  High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins.

Authors:  L Havard; S Rahmouni; J Boniver; P Delvenne
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

8.  Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines.

Authors:  C D Woodworth; S Simpson
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection.

Authors:  C D Woodworth; S Cheng; S Simpson; L Hamacher; L T Chow; T R Broker; J A DiPaolo
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

10.  NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix.

Authors:  Asha Nair; Manickam Venkatraman; Tessy T Maliekal; Balaraman Nair; Devarajan Karunagaran
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867

View more
  42 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer.

Authors:  Jing Wu; Xia Xue; Bin Zhang; Hongmei Cao; Feng Kong; Wen Jiang; Juan Li; Deqing Sun; Ruichen Guo
Journal:  Tumour Biol       Date:  2016-06-07

3.  The stress granule protein G3BP1 recruits protein kinase R to promote multiple innate immune antiviral responses.

Authors:  Lucas C Reineke; Richard E Lloyd
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

Review 4.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

5.  Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.

Authors:  Fang Li; Jinquan Cui
Journal:  Med Oncol       Date:  2015-06-12       Impact factor: 3.064

6.  The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16INK4a and NF-κB expression in head and neck squamous cell carcinomas in Southwestern Iran.

Authors:  Fatemeh Pakdel; Ali Farhadi; Tahereh Pakdel; Azadeh Andishe-Tadbir; Parnian Alavi; Abbas Behzad-Behbahani; Mohammad J Ashraf
Journal:  Braz J Microbiol       Date:  2020-11-09       Impact factor: 2.476

Review 7.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

Review 8.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

9.  NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.

Authors:  Daria A Gaykalova; Judith B Manola; Hiroyuki Ozawa; Veronika Zizkova; Kathryn Morton; Justin A Bishop; Rajni Sharma; Chi Zhang; Christina Michailidi; Michael Considine; Marietta Tan; Elana J Fertig; Patrick T Hennessey; Julie Ahn; Wayne M Koch; William H Westra; Zubair Khan; Christine H Chung; Michael F Ochs; Joseph A Califano
Journal:  Int J Cancer       Date:  2015-06-23       Impact factor: 7.396

10.  Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.

Authors:  Yunying Zhou; Qishu Zhang; Ge Gao; Xiaoli Zhang; Yafei Liu; Shoudao Yuan; Xiaowei Wang; Jason J Chen
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.